Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
12/30/2009 | CN100575365C Loose knot total polysaccharide and preparation method and usage thereof |
12/30/2009 | CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor |
12/30/2009 | CN100575334C Substituted 2-dialkylaminoalkylbiphenyl derivatives |
12/30/2009 | CN100574795C Chinese traditional medicine for treating myocarditis |
12/30/2009 | CN100574780C Compositions against inflammatory processes |
12/30/2009 | CN100574769C Nerve growth factor production inhibitor and external preparation for skin, cosmetic, quasi medicine, itch prophylactic and therapeutic agent and atopic dermatitis therapeutic agent |
12/30/2009 | CN100574768C An anticancer medicinal composition, preparing method and use thereof |
12/30/2009 | CN100574761C Mycophenolate mofetil dry suspension agent |
12/30/2009 | CN100574628C Orally taken health product for eliminating fatigue of racing pigeon |
12/30/2009 | CA2729546A1 Compounds and compositions as kinase inhibitors |
12/30/2009 | CA2728694A1 Substituted pyrimidone derivatives |
12/30/2009 | CA2728652A1 Use of cyclolignans for the treatment of a hyperactive immune system |
12/30/2009 | CA2728137A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
12/30/2009 | CA2728123A1 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
12/30/2009 | CA2728112A1 Pharmaceutical composition and extract of poria for treating a disease induced from immune disorder |
12/30/2009 | CA2727455A1 Heteroaryl compounds and uses thereof |
12/30/2009 | CA2726465A1 Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof |
12/29/2009 | US7638679 Screening for agents that modulate tolerance to an immunogen; delivering a nucleic acid that directs expression of the immunogen to the liver of an animal, resulting in sustained expression of the immunogen in the liver. |
12/29/2009 | US7638643 Process for producing soybean saponin-containing material |
12/29/2009 | US7638630 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
12/29/2009 | US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof |
12/29/2009 | US7638546 Imidazolyl derivatives |
12/29/2009 | US7638540 Benzofuran compound and medicinal composition containing the same |
12/29/2009 | US7638538 4-chloro-N-({5-[({2-[(2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]amino}ethyl)amino]-2-oxoethyl}amino)sulfonyl]thien-2-yl}methyl)benzamide; inhibitor of jun N-terminal kinase 2 and 33 inhibitor; autoimmune disorders |
12/29/2009 | US7638523 e.g. tert-butyl 2-(4-(2-(4-(2-(diethylamino)ethoxy)phenylamino)pyrimidin-5-yl)-2-fluorobenzamido)acetate; C-kit kinase receptor or stem cell factor inhibitors; asthma allergic sinusitis and rhinitis, atopic and allergic dermatitis, allergic contact rheumatoid arthritis, multiple sclerosis, lupus etc. |
12/29/2009 | US7638521 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
12/29/2009 | US7638492 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
12/29/2009 | US7638480 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
12/29/2009 | US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
12/29/2009 | US7638323 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering |
12/29/2009 | US7638134 Insertion sites in fowlpox vectors |
12/29/2009 | US7638121 Preparing human recipient for graft; administer to individual irradiated thymocytes, CD-2 monoclonal antibody, donor peripheral blood progenitor and immunosuppressants; monitor for transplant rejection |
12/29/2009 | CA2466490C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
12/29/2009 | CA2451932C Pyrrolopyrimidines as protein kinase inhibitors |
12/29/2009 | CA2447521C Delivery of antihistamines through an inhalation route |
12/29/2009 | CA2446798C Solid pharmaceutical compositions comprising cyclosporin |
12/29/2009 | CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors |
12/29/2009 | CA2423296C N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
12/29/2009 | CA2415683C Indoloquinazolinones |
12/29/2009 | CA2348993C Substituted phenethylsulfones and method of reducing tnf.alpha. levels |
12/29/2009 | CA2300208C Immunostimulatory and metastasis inhibiting fermented vegetal material |
12/29/2009 | CA2299548C Composition and method for regulating cell proliferation and cell death |
12/29/2009 | CA2264802C Antioxidant derived from lentil and its preparation and uses |
12/24/2009 | US20090318687 Methods of Treating or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds |
12/24/2009 | US20090318566 Gossypol derivatives, production method thereof and uses of same |
12/24/2009 | US20090318546 Chromen-2-One Derivatives |
12/24/2009 | US20090318523 Benzoisoindole derivatives and their use as ep4 receptor agonists |
12/24/2009 | US20090318509 Oxime Derivatives as Inhibitors of Macrophage Migration Inhibitory Factor |
12/24/2009 | US20090318463 Indolylmaleimide Derivatives |
12/24/2009 | US20090318457 Methods of Using hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide |
12/24/2009 | US20090318452 INHIBITORS OF p38 |
12/24/2009 | US20090318448 Inhibitors of Bruton's Tyrosine Kinase |
12/24/2009 | US20090318444 Tetrahydro- and dihydroquinazolinones |
12/24/2009 | US20090318435 Pyrazolopyridines and analogs thereof |
12/24/2009 | US20090318407 Inhibitors of protein kinases |
12/24/2009 | US20090318397 Combination of Azelastine and Steroids |
12/24/2009 | US20090318359 Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains |
12/24/2009 | US20090318357 Molecules Preferentially Associated with Effector T Cells or Regulatory T Cells and Methods of Their Use |
12/24/2009 | US20090318342 Compounds |
12/24/2009 | US20090318341 Methods of using OSK1 peptide analogs |
12/24/2009 | US20090318337 Compositions and methods for activating innate and allergic immunity |
12/24/2009 | US20090318336 Deuterated Cyclosporine Analogs and Methods of Making the Same |
12/24/2009 | US20090317480 Chimeric immunomodulatory compounds and methods of using the same-ii |
12/24/2009 | US20090317455 Reverse targeting lipid vesicle |
12/24/2009 | US20090317428 Immunogenic T-Helper Epitopes From Human Tumour Antigens and Immunotherapeutic Methods Using Said Epitopes |
12/24/2009 | US20090317425 Refrigerator-temperature stable influenza vaccine compositions |
12/24/2009 | US20090317410 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
12/24/2009 | US20090317398 a labeled polyclonal antibody, monoclonal antibody or antigen-binding fragment which preferentially binds to a polypeptide that chemoattracts peripheral blood monocytes or T-cells; proteins which control development, differentiation, trafficking and physiology of mammalian cells; immunology |
12/24/2009 | US20090317389 Fusion molecules and methods for treatment of immune diseases |
12/24/2009 | US20090317385 Methods Using Immunomodulatory Compounds for Modulating Level of CD59 |
12/24/2009 | US20090317382 Use of effector-function-deficient antibodies for treatment of auto-immune diseases |
12/24/2009 | US20090317381 Clearance of abnormal iga1 in iga1 deposition diseases |
12/24/2009 | US20090317357 Methods for treating or preventing autoimmune disease using histamine h1 receptor-blocking agents |
12/23/2009 | WO2009155475A1 Paediatric compositions for treating1 multiple sclerosis |
12/23/2009 | WO2009155362A1 Small molecule hematopoietic growth factor mimetic compounds and their uses |
12/23/2009 | WO2009155041A2 Method to modulate hematopoietic stem cell growth |
12/23/2009 | WO2009154565A1 Combination therapies against cancer |
12/23/2009 | WO2009154230A1 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
12/23/2009 | WO2009154051A1 Immunostimulating agent |
12/23/2009 | WO2009153721A1 Nicotinamide derivatives |
12/23/2009 | WO2009153720A1 Nicotinamide derivatives |
12/23/2009 | WO2009153514A1 Phenyl-alkyl piperazines having a modulating activity of tnf |
12/23/2009 | WO2009153414A1 Modified beta-lactoglobulins for immunotherapy of milk allergy |
12/23/2009 | WO2009153296A1 Pharmaceutical composition comprising a non-steroidal glucocorticoid receptor agonist in combination with a dual histamine antagonist |
12/23/2009 | WO2009152917A2 Stabilization of the composition of a mixture |
12/23/2009 | WO2009131604A3 Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof |
12/23/2009 | WO2009129502A3 Immunotherapies employing self-assembling vaccines |
12/23/2009 | WO2009117365A3 Vaccine compositions for inducing immune responses against components of drusen |
12/23/2009 | WO2009068996A3 Conjugated beta-1,3-linked glucans |
12/23/2009 | WO2009020534A3 Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines |
12/23/2009 | WO2008091643A3 Evaluating synergy of combinations comprising an antibody in immune suppressive pathways concurrent to immunotherapy |
12/23/2009 | EP2135611A1 Pregn-5-en-20-yne-3,7,17-triol derivatives for use in therapy |
12/23/2009 | EP2135605A2 Therapeutic delivery of carbon monoxide |
12/23/2009 | EP2134349A1 Aminoalkyl glucosamine phosphate compounds for treating autoimmune diseases |
12/23/2009 | EP1549651B1 Pyrimidopyrimidones as kinase inhibitors |
12/23/2009 | EP1450822B1 Polyalkylene oxide conjugates of thiol-containing drugs |
12/23/2009 | EP1425295B1 Modified peptides and their use for the treatment of autoimmune diseases |
12/23/2009 | EP1312259B1 Type iii allergic inflammation model animal |
12/23/2009 | EP1296972B1 Arylmethylamine derivatives for use as tryptase inhibitors |
12/23/2009 | EP1164874B1 Use of negatively charged, non-digestible polysaccharide hydrolysates for reducing transport through tight junctions of the intestin |